Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities
Net income (loss)	$ (1,110,351)	$ 13,190,273
Gain (loss) from discontinued operations	(80,422)	14,471,162
Net loss from continuing operations	(1,029,929)	(1,280,889)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Restricted stock awards		60,000
Depreciation and amortization	1,225	565
Loss on extinguishment of debt	30,069
Share-based compensation	15,625
Amortization of deferred financing cost	4,405	322
Provision for bad debt	20,000
Changes in operating assets and liabilities:
Accounts receivable	9,812	(231,503)
Inventory	(38,427)
Prepaid expenses and other current assets	(529)	(3,401)
Accounts payable and accrued expenses	644,606	186,572
Deferred revenue	33,390	45,041
Net cash used in operating activities of continuing operations	(309,754)	(1,223,293)
Net cash used in operating activities of discontinued operations	(16,365)	(4,930,689)
Net cash used in operating activities	(326,119)	(6,153,982)
Cash flows from investing activities
Purchase of property and equipment	(6,633)	(1,751)
Payments for acquisition of subsidiary		(420,000)
Net cash used in investing activities of continuing operations	(6,633)	(421,751)
Net cash provided by investing activities of discontinued operations		20,892,667
Net cash provided by (used in) investing activities	(6,633)	20,470,916
Cash flows from financing activities
Proceeds from notes payable	413,000	500,000
Payment of preferred stock interest	(60,000)	(35,000)
Net cash provided by financing activities of continuing operations	353,000	465,000
Net cash used in financing activities of discontinued operations		(13,872,514)
Net cash provided by (used in) financing activities	353,000	(13,407,514)
Effect of exchange rate fluctuations on cash	(456)	(11,281)
Net change in cash and restricted cash	19,792	898,139
Cash and restricted cash, beginning of the period	107,727	77,295
Cash and restricted cash, end of the period	127,519	975,434
Supplemental disclosure of cash flow information:
Interest paid		946,691
Income taxes paid
Supplemental disclosure of non-cash investing and financing information:
Fair value of warrants issued in connection with line of credit and promissory notes		62,294
Accrued payables and short-term note directly paid off by credit facility		62,379
Accrual of preferred stock interest	120,000	31,575
Warrant repricing adjustment		104,638
Conversion of notes payable to Series A Preferred Stock		500,000
Issuance of common stock for payment of accrued preferred stock interest	104,931
Issuance of common stock as payment of accounts payable and accrued expenses	105,000
Common Stock [Member]
Cash flows from operating activities
Net income (loss)
Supplemental disclosure of non-cash investing and financing information:
Warrant repricing adjustment
Issuance of Stock for acquisition of subsidiary		2,700,000
Series B Preferred Stock [Member]
Supplemental disclosure of non-cash investing and financing information:
Issuance of Stock for acquisition of subsidiary		$ 687,000